skip to Main Content

Publications 2014

Niraparib (MK-4827), a novel poly(ADP-Ribose) polymerase inhibitor, radiosensitizes human lung and breast cancer cells.

Bridges KA, Toniatti C, Buser CA, Liu H, Buchholz TA, Meyn RE. (2014)
Oncotarget. 2014 Jul 15;5(13):5076-86.

More info on PubMed.gov

Development of a neuromedin U-human serum albumin conjugate as a long-acting candidate for the treatment of obesity and diabetes.

Comparison with the PEGylated peptide.
Neuner P, Peier AM, Talamo F, Ingallinella P, Lahm A, Barbato G, Di Marco A, Desai K, Zytko K, Qian Y, Du X, Ricci D, Monteagudo E, Laufer R, Pocai A, Bianchi E, Marsh DJ, Pessi A. (2014)
J Pept Sci. 2014 Jan;20(1):7-19.

More info on PubMed.gov

Immunogenicity and therapeutic efficacy of a dual-component genetic cancer vaccine cotargeting carcinoembryonic antigen and HER2/neu in preclinical models.

Aurisicchio L, Peruzzi D, Koo G, Wei WZ, La Monica N, Ciliberto G. (2014)
Hum Gene Ther. 2014 Feb;25(2):121-31.

More info on PubMed.gov
Back To Top